Preparation and application of modified peach gum polysaccharide in the repair of central nervous system injury Authors: An Wang, Zhangheng Huang, Haoqi Chen, Qiqiang Xing, Jing Wang, Peiling Dai, Wangying Dai Published: 2026 ABSTRACT Spinal cord injury (SCI) is an irreversible neurological injury that leads to severe motor dysfunction and neurological deficiencies, imposing a large social load. Due to the difficulty of the SCI procedure, the prognosis is normally bad. In recent years, naturally derived hydrogels have garnered increasing attention. Peach gum (PG) primarily consists of macromolecular polysaccharides with abundant hydroxyl and carboxyl groups on its branched chains, making it amenable to modification. This study is the first to prepare carboxymethylated peach gum polysaccharide (CPG) using PG as the raw material and load it with nerve growth factor (NGF) to improve the adverse microenvironment post-SCI and promote axonal regeneration. Carboxymethylation modification of PG was done, and its effective change was verified by infrared spectroscopy and degree of replacement measurements. After loading NGF, its characterization was examined. The mechanical characteristics, thermal behavior, and self-healing ability of CPG + NGF were shown to be outstanding in the results. Cell experiments demonstrated that, compared to the sham-operated group, CPG + NGF significantly promotes neurite outgrowth and development in PC-12 cells. Ultimately, CPG + NGF was implanted into the injured spinal cords of rats, and research demonstrated that CPG + NGF significantly improves the microenvironment of the affected areas, fosters axonal regeneration in severely damaged spinal cord regions, and enhances motor function in the rats. The modified PG biopolymer scaffold developed in this study exhibits superior mechanical strength, excellent cytocompatibility, and enhanced biological functionality. In summary, this research provides new insights into the application of biomacromolecules in SCI repair. Introduction Spinal cord injury (SCI) is one of the most serious clinical disorders, usually resulting in severe neurological impairment. Because of the rising incidence rate, it has grown to be a big load for people, families, and society [1]. Current clinical treatments for SCI include traditional drug therapy, surgical treatment, cell therapy, gene therapy, etc. But relying solely on current treatment methods cannot completely repair SCI; they can only improve symptoms specifically and reduce complications from secondary injury [2–5]. As a result, the incidence and development of SCI, along with the reduction of secondary spinal cord damage following injury, the promotion of spinal cord nerve repair, and the recovery of motor function have long focused and hot research hotspots. With the development of tissue engineering, neural regeneration techniques based on bio-scaffolds have become a reliable option for SCI. Bio-material scaffolds employed in spinal cord regeneration can be categorized based on the structural needs of spinal cord injury (SCI) and the physical and biological properties of the desired tissue structure. This includes hydrogels, biodegradable scaffolds, and micro-or nano-particle-based scaffolds, among others [6]. One important element that controls the application field of hydrogel materials is the source of them. Hydrogels are typically classified into natural hydrogels and synthetic hydrogels based on their material origins. Natural hydrogels mainly include protein-based materials such as silk fibroin (SF) and gelatin (Gel), as well as polysaccharides like hyaluronic acid (HA) and chitosan (CTS), which have been explored for SCI repair. Natural hydrogels not only exhibit excellent biocompatibility and degradability but also retain certain biological activities, making them considered ideal candidates for SCI treatment [6]. However, their poor mechanical properties (such as stiffness and tensile strength) and single biological function limit their applications [7]. Peach gum (PG) is a natural homopolysaccharide commonly in nature. Besides peach trees, apricot trees, plum trees, cherry trees and other Rosaceae species also secrete similar gelatinous substances when stimulated by external factors. Peach trees are cultivated worldwide, but only a small portion of them are processed and utilized [7]. PG is a typical Chinese medicine that has been used in the past to cure dysentery, diabetes, and other ailments in China. Research by Simas and colleagues has shown that PG consists of arabinose, galactose, glucuronic acid, xylose, mannose, and rhamnose, and that the source of PG and different hydrolysis methods have almost no effect on the composition of PG, only affecting the content of each monosaccharide [8]. The analysis of PG using Fourier transform infrared spectroscopy shows prominent signal peaks at 3400 cm⁻¹ and 1413 cm⁻¹, suggesting that PG contains a substantial amount of -OH and -COOH groups [9]. PG has good adsorption performance and has antioxidant characteristics [10]. Yang et al. evaluated the antioxidant properties of PG by determining its capacity to neutralize free radicals. The results indicated that the hydrolysis method of crude gum arabic affects the antioxidant activity of PG, and the antioxidant activity of PG is related to its concentration. The concentration of PG rises to 100 mg/mL, which means that the DPPH free radical scavenging efficiency rises to 91.7% [10]. This study used peach gum (PG) as the raw material to prepare carboxymethylated peach gum polysaccharide (CPG) loaded with neurotrophic factors, investigating its effects on the recovery of neurological function in rats after SCI. Initially, correlation analysis and characterization methods confirmed the successful carboxymethylation modification and its favorable structural and mechanical properties. Later in vitro cell experiments showed that CPG has good biocompatibility and promotes axonal growth and development, and further proved that CPG is very biocompatible. Ultimately, CPG + NGF was implanted into a rat model of spinal cord injury. The results indicated that CPG + NGF effectively improves the microenvironment at the injury site, promotes the repair of damaged axons, and enhances the motor function of the rats. PG polysaccharides constitute over 80% of its composition, exhibiting remarkable hydrophilicity. Specifically, these polysaccharide molecules contain abundant hydrophilic groups that rapidly absorb water upon contact, causing immediate swelling. The molecular chains interconnect through hydrogen bonds and other forces, forming a stable network structure that traps water molecules, resulting in a viscous, gel-like consistency. The carboxymethyl modification did not destroy the molecular structure and related active groups of pectin polysaccharide, but introduced carboxymethyl groups at the hydroxyl substituent position. Therefore, the stable hydrogel network structure is its characteristic. NGF is incorporated into CPG via simple physical cross-linking. In summary, the modified peach gum polysaccharide prepared in this study possesses superior mechanical properties and biological functions compared to conventional natural-source hydrogels. This research provides a novel approach for utilizing natural macromolecules in SCI repair (Fig. 1).Fig. 1Preparation strategy of CPG + NGF and its application in SCI. Schematic illustration of the synthesis of CPG + NGF. The colloids possess significant multifunctionality as well as excellent chemical, biological, and mechanical properties. By encapsulating NGF within their porous structure, they exhibit desirable release characteristics. After implanting the colloids into the spinal cord of rats with injury, they can improve the spinal microenvironment and promote the regeneration of neural axons Preparation strategy of CPG + NGF and its application in SCI. Schematic illustration of the synthesis of CPG + NGF. The colloids possess significant multifunctionality as well as excellent chemical, biological, and mechanical properties. By encapsulating NGF within their porous structure, they exhibit desirable release characteristics. After implanting the colloids into the spinal cord of rats with injury, they can improve the spinal microenvironment and promote the regeneration of neural axons Materials and methods Materials and animals Peach gum from farms (Shanghai, China). Neurotrophic growth factor (NGF) with a molecular weight of 15.4 kDa is sourced from Sigma-Aldrich Corporation, USA. Penicillin-streptomycin, trypsin-EDTA, and fetal bovine serum (FBS) were purchased from Gibco (Carlsbad, CA). The CCK-8 kit, live/dead kit, Hurst, and 4’, 6-diamidino-2-phenylindole (DAPI) were acquired from Beyotime (Shanghai, China). The National Certified Cell Culture Collection Center (Shanghai, China) provided the phenochromocytoma cells 12 (PC-12). Dulbecco’s Modified Eagle’s Medium (DMEM) was acquired from Saibecon in Shanghai, China. Sprague Dawley (SD) rats, 9-week-old, n = 50, with a mean weight of 210 g. Rats were kept in a 12-h light/dark cycle in accordance with laboratory regulations and were maintained at a temperature of 20–22 °C with 50% relative humidity. The Yangzhou University (yzu-lcyxy-n488) Animal Experimental Ethics Committee gave its approval for this study. Animal feeding and well-being testing were done according to the standards of the Laboratory of Yangzhou. Alkaline hydrolysis of raw PG polysaccharides Raw PG is very hard and swells when it comes into contact with water; even PG powder is almost insoluble in water (Fig. 2A). After natural drying, impurities are eliminated from the harvested PG, which is then milled into a fine powder and passed through a 160-mesh sieve, with the resulting coarse PG powder being collected. Dissolve 5.00 g of raw PG powder in 150 mL of 0.01 mol/L NaOH aqueous solution, stir thoroughly until dissolved, continue stirring for 50 min while heating in a water bath at 85 °C, then adjust the raw PG solution to pH neutral with 1 mol/L HCl, and finally collect the product after freeze-drying to obtain the alkali-hydrolyzed peach gum (AHPG).Fig. 2The formation colloids. A Physical images of PG, PG powder and CPG. (n = 3). B Intrinsic viscosity of AHPG. Black represents ηsp/c, red represents lnηr/c. (n = 3). C Infrared spectra of PG, AHPG, and CPG. (n = 3). D Conductivity change curve of AHPG solution. (n = 3). E Conductivity change curve of CPG solution. (n = 3) The formation colloids. A Physical images of PG, PG powder and CPG. (n = 3). B Intrinsic viscosity of AHPG. Black represents ηsp/c, red represents lnηr/c. (n = 3). C Infrared spectra of PG, AHPG, and CPG. (n = 3). D Conductivity change curve of AHPG solution. (n = 3). E Conductivity change curve of CPG solution. (n = 3) Preparation and characterization of carboxymethylated PG polysaccharide Dissolve 4.00 g of AHPG in 50 mL of anhydrous methanol, stir mechanically at room temperature for 30 min to ensure complete swelling, then heat to 50 °C. Under continuous stirring, add dropwise 10 mL of a 30% NaOH aqueous solution using a constant pressure dropping funnel, and alkalinize for 30 min. Continue to slowly add 3.75 g of ClCH2COOH and react for 15 h. After the reaction is completed, adjust the solution pH to neutral with concentrated HCL, perform vacuum filtration, wash the filter cake three times with anhydrous methanol to remove impurities, dry in an oven at 60 °C until constant weight, and collect the product to obtain CPG. In the CPG synthesis process, NGF-loaded CPG was prepared by adding 1 milliliter of PBS solution containing 10.0 micrograms of NGF to every 60 mg of CPG. The dose of NGF is based on early studies that demonstrated this concentration of NGF can significantly promote the repair of SCI [11]. Using a 0.2 mol/L NaCl solution as the solvent, the intrinsic viscosity [η] of AHPG was measured in an intelligent thermostatic water bath at a water temperature of 25, and the result was determined using the infinite dilution extrapolation method using a Ubbelohde viscometer. Using the Mark-Houwink-Sakurada equation, which was developed by Wei et al. [12], the intrinsic viscosity-average molecular weight of AHPG is computed. An infrared spectral study was done on PG, AHPG, and CPG using a Fourier transform infrared spectrometer (Nicolet iS50, Thermo Fisher, USA), with a scanning range from 500 cm-1 to 4000 cm-1. Using deionized water as the solvent, AHPG and CPG were prepared into a solution with a concentration of 0.5 wt%. The Zeta potential of the solution was assessed using a Zetasizer Nano ZS90 laser scattering particle size analyzer (Malvern, UK), with three measurements taken in parallel. The degree of substitution of AHPG and CPG was determined by potentiometric titration. Accurately weigh 0.5 g of AHPG and CPG, dissolve in 20 mL of 2 mol/L HCl aqueous solution, stir and acidify for 10 min, then dialyze until neutral and free of Cl-, freeze-dry, and collect the acidified AHPG and CPG. Weigh 0.04 g of dried and acidified AHPG and CPG, then dissolve in 20 mL of 0.05 mol/L NaOH standard solution. Titrate this solution with a 0.05 mol/L HCl standard solution and create a titration curve that illustrates the change in conductivity relative to the volume of HCl used. Determine the volume of HCl standard solution consumed at the endpoint of the titration, and calculate the degree of substitution (DS) for both AHPG and CPG. After complete curing of the CPG, visually observe its color, shape, and viscosity. Once the CPG is fully cured, it will be freeze-dried and then cut in half with tweezers (freeze-drying temperature: –50 °C, vacuum pressure: 10–30 mbar, freeze-drying time: 72 h, sample thickness: 9 micrometers). The cross-section is examined using a scanning electron microscope (SEM) after being sputter-coated with gold. The mechanical characteristics were assessed by means of a universal testing equipment (CMT6103, USA) at a strain rate of 1 mm/min in order to perform the compression test. We calculated the compression modulus by measuring the slope of the linear portion of the stress-strain curve within the 5% to 10% strain range, with each group utilizing three replicate samples. Rheological testing To determine the final critical strain point of the colloid, we conducted a thorough strain amplitude scanning test at a constant frequency of 1 Hertz, covering a comprehensive strain spectrum from 0.1% to an extensive 1000%. To evaluate the injectability of the colloid, we added a non-reactive tracer dye to enhance visualization, thereby gaining a clearer understanding of its flow characteristics. Subsequently, the colloid was carefully placed into a syringe equipped with a precise 26-gauge needle, ensuring its smooth transfer. This setup facilitated the direct injection of the colloid onto designated plates, further validating its suitability for injection-based applications. The elemental composition of particles was analyzed through energy-dispersive X-ray spectroscopy (EDX) mapping. The sample was dispersed in anhydrous ethanol, ultra-sonicated for 15 min, then 10 µL of the solution was taken and dropped onto a carbon-film-coated copper grid, allowing it to air-dry at room temperature. Degradation of colloids and release of drugs The degradation behavior of CPG is assessed by measuring weight loss. In short, immerse 200 microliters of CPG in 1 milliliter of PBS, maintaining the temperature at 37 degrees Celsius. Record the remaining weight of the CPG on day 0, day 8, day 16, day 24, and day 32. Use a 26-gauge needle to inject 1 milliliter of CPG into the subcutaneous tissue of the back of a healthy rat. Carefully capture the remaining CPG at different time point safter jection. During each assessment, carefully excise the rat’s skin to expose the CPG and take photographs. NGF is used for various applications, including the repair of SCI. In vitro release assessment method employing lysozyme (lys, Sigma), which has a molecular weight of 14.7 kD and an isoelectric point (pI) of 10.5 [11]. Due to the similarity in molecular weight and charge between lysozyme and NGF, and the affordability and easy availability of lysozyme, it is used as a substitute for NGF [13]. Fluorescein isothiocyanate (FITC)-labeled lysozyme is added to the CPG synthesis process. To evaluate the degradation properties of CPG, PBS is carefully added to the vials. Next, these vials are put into an incubator with an oscillating temperature of 37 °C and a speed of 70 rpm. Over time, PBS samples are collected, and fresh buffer is supplemented to maintain experimental conditions. The amount of lysozyme released into the PBS is quantified using a multifunctional microplate reader (Tecan Infinite M200, Switzerland). Cytotoxicity test Colloidal samples are usually sterilized using irradiation sterilization methods (Irradiation dose is usually between 8 and 10 kGy). The cytotoxic effects of colloids were evaluated through live/dead cell staining and the CCK-8 (Thiazolyl Blue) viability assay. PC-12 cells were seeded in 24-well plates embedded with colloids and observed at time points of 1 day, 3 days, and 5 days. The Calcein-AM/PI/Propidium Iodide (PI) dual staining kit specifically labels live cells in green and non-viable cells in red. Prior to staining, the culture medium was carefully replaced with a PBS solution containing the aforementioned dyes. For the best staining possible, the culture plate was then incubated for thirty min. Ultimately, cell responses were examined with a confocal laser scanning microscope (CLSM). Additionally, to further confirm the cytotoxicity assessment results, PC-12 cells were co-cultured with colloids in 96-well plates for 24 and 48 h. After cultivation, 10 microliters of CCK8 solution (Servicebio, G4103) were added to each well, followed by an additional 2-h incubation. A Thermo microplate reader was used to precisely measure the absorbance at 450 nanometers in order to determine the direct sign of cell viability. In vitro assessment of axonal growth The Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% of the serum from the horse and 5% of the fetal bovine serum (both from Gibco) was used to cultivate the PC-12 cells. Using a 1:2 dilution procedure, cells are passaged every two days and then separated with 0.25% trypsin. Next, the cells are placed onto 14 mm diameter coverslips that have been pre-coated with poly-L-lysine at a density of 5 × 104 cells per well. The cells are subsequently seeded onto culture plates with various substrate controls, PG, CPG, and CPG + NGF. The culture plates are then incubated at 37 °C in a 5% CO2 atmosphere. Following a three-day culture period, the morphology of the neurites is evaluated using a confocal laser scanning microscope (CLSM). Last but not least, ImageJ software (National Institutes of Health, Bethesda, MD, USA) is used to measure the length from the cell body to the tip of the neurites. In vitro cell development studies Continue to seed the previously obtained PC12 cells onto culture plates coated with various matrices. On the seventh day, stain with neuronal-specific markers, namely type III β-tubulin (Tuj1). Three distinct random fields were captured using a state-of-the-art inverted microscope (Axio Vert.A1) made by Leica, Germany. Surgical procedures and treatment of rats Using the rat spinal cord complete transection model. SD rats were anesthetized with 2% isoflurane to induce a surgical plane of anesthesia, and a 2 mm rectangular defect was created at the center of the T10 vertebra. Five different groups were established: 1. Sham surgery group: This cohort underwent the surgical procedure, including laminectomy, but crucially, no SCI was induced. 2. Injury group: After inducing SCI, this group received no treatment and served as a baseline for comparison. 3. PG group: PG was placed in the injured area. 4. CPG group: CPG was implanted at the injury site. 5. CPG + NGF group: CPG enriched with NGF was implanted. Finally, the incision site, including muscle and skin, was carefully sutured with sterile needle-containing sutures. Postoperatively, to prevent infection, cefuroxime was administered intraperitoneally, and the rats were allowed to recover naturally at room temperature. Assessment of spinal cord function recovery To evaluate the recovery of hindlimb function, the BBB scoring scale was used for weekly assessments post-surgery, continuing for 12 weeks, to analyze the process of motor function recovery [14]. During the post-SCI period, the footprint Test was conducted at the 12th week post-SCI. Non-toxic ink was used to paint the hind paws of each rat black, and then the rats were allowed to perform the footprint experiment on a new white paper strip (size 21 × 59.4 cm²). Measurements included stride length and swing distance. Using the average of five steps for each case, statistical comparisons were performed. Spinal cord tissue dissection and HE and LFB staining After twelve weeks of surgery, take sections of the spinal cord and stain with Luxol Fast Blue (LFB) and hematoxylin and eosin (H&E). The following is the particular method: Rats were anesthetized with isoflurane combined with 2% pentobarbital sodium solution. After perfusing the heart with 4% paraformaldehyde, quickly dissect the T9-T11 segment of the spinal cord, fix it overnight in 4% (w/v) paraformaldehyde, and then use a cryostat (Leica CM 1900) to cut horizontal sections 14 micrometers thick for histological staining studies. Immunofluorescence analysis Extract the T9-T11 segment spinal cord from all experimental rats and immersed in a cold 1x PBS solution containing 4% PFA for fixation. After initial fixation, the spinal cord tissue underwent a precise dissection process and was then cryopreserved in 20% and 30% sucrose solutions at 4 °C, respectively. Then, in liquid nitrogen, the spinal cord was quickly submerged for freezing and kept at 80 °C for later use. Using a Leica CM 1900 cryostat, sections with a thickness of 14 micrometers were sliced. These sections were then subjected to three rigorous washes with 0.01 M PBS and incubated overnight at 4 °C with primary antibodies specific to the target antigen. The main antibodies utilized in this study comprise mouse monoclonal antibodies against Tuj1 (Proteintech, 66375-1-lg, dilution ratio 1:100), which serve as indicators of immature neurons. Antibodies targeting CS56 (Proteintech, 14420-1-AP, dilution ratio 1:100) were employed to label chondroitin sulfate proteoglycans (CSPGs). Mouse monoclonal anti-glial fibrillary acidic protein (1:200 dilution; Sigma-Aldrich, USA); To label the astrocytes, FITP (1:200 dilution) was used. Three PBS washes were performed on the spinal cord slices following primary antibody incubation. Then, the sections were incubated at 37 °C for 1.5h, and a secondary antibody solution containing Alexa Fluor 488 goat anti-rabbit antibody (Abcam, dilution ratio 1:100) and Alexa Fluor 594 goat anti-mouse (Thermo, dilution ratio 1:500) was added. After the secondary antibody incubation is complete, the sections are rinsed three times with PBS and then incubated with DAPI for 3 min in the dark to stain the cell nuclei. After washing with PBS, excess DAPI is removed, and the slides are mounted with glycerol and a coverslip. Finally, a fluorescence microscope (BX-51; Olympus) was used to capture images of randomly chosen fields from each group. Detection of the level of related molecules in the spinal cord by enzyme-linked immunosorbent assay (ELISA) Add PBS at a mass-to-volume ratio of 1:9, homogenize the tissue using a tissue homogenizer, and centrifuge at 10,000 × g for 10 min. Collect the supernatant for testing. Do not add samples to the blank wells. For the standard wells, add 50 μL of the prepared standard solution, followed by 100 μL of horseradish peroxidase. For the test wells, add 50 μL of the sample followed by 100 μL of horseradish peroxidase. Seal the wells with a plate membrane, gently shake to mix, and incubate at 37 °C for 1 h. Dilute the 20X concentrated washing solution 20-fold with ddH2O and set aside. Carefully remove the plate membrane, discard the liquid, and dry the wells. Add full washing solution to each well, let it sit for 1 min, then discard. Repeat this process 5 times. Gently shake to mix, and incubate at 37 °C in the dark for 15 min to develop the color. Add 50 μL of termination solution to each well to stop the reaction, then measure the absorbance (OD value) at 450 nm. Toxic effects of hydrogels on in vivo tissues and organs At week 12 post-surgery, the spinal cord tissue was dissected, and important organs were excised and preserved overnight in 4% (w/v) paraformaldehyde. This was followed by dehydration using graded ethanol and embedding in paraffin. The tissue blocks were sliced into sections that were 4-micrometer-thick and then stained with H&E for histological examination. Statistical analysis All the data were analyzed using a specific software (GraphPad Prism 9.0), and the data were expressed as means ± standard deviation. The p value < 0.05 was statistically significant. Student’s t tests were used to analyze the significance of differences between the two groups. A one-way ANOVA was used to evaluate the differences between the various groups for pairwise comparisons, and a Tukey post-hoc test was used for the post-hoc test. Ethic statement This study was approved by the Animal Experimental Ethics Committee of the Yangzhou University (yzu-lcyxy-n488). Animal feeding and welfare tests were performed according to the standards of the Laboratory of Yangzhou. Results Characterization of PG before and after carboxymethylation modification A popular technique for the treatment of organic materials is alkaline hydrolysis (Fig. 2A). After alkaline hydrolysis treatment, the PG molecular chains break and extend, resulting in a significant increase in the solubility of PG (Fig. S1). The Ubbelohde viscometer (Fig. 2B) was used to measure the intrinsic viscosity of AHPG. The intrinsic viscosity value [η] of AHPG was calculated using the extrapolation method at infinite dilution and was substituted into the Mark-Houwink-Sakurada empirical equation provided by Wei et al., resulting in a viscosity-average molecular weight of AHPG of 6.27×105 g/mol. The AHPG obtained through alkaline hydrolysis has a lower viscosity and better solubility. The infrared spectra of PG and AHPG show that they are basically identical, with the functional group signal peaks overlapping. After alkaline hydrolysis, AHPG does not exhibit new functional groups, indicating that the alkaline hydrolysis does not alter the basic structure of PG. It merely reduces the molecular chains by disrupting certain inter-and intra-molecular interactions of PG molecules, resulting in lower molecular weight and enhanced solubility. Research indicates that the pronounced absorption peak around 3300 cm-1 corresponds to the stretching vibration of-OH, while the less intense absorption peak near 2926 cm-1 relates to the stretching vibration of C-H. The peaks at 1599 cm-1 and 1417 cm-1 represent the symmetric and asymmetric stretching vibration signals of COO-, and the peak at 1020 cm-1 is recognized as the characteristic signal peak of arabinose [15]. The signal at 1417 cm-1 is more pronounced for carboxymethylated CPG because of the increased presence of carboxyl functional groups, while a new peak appears at 1326 cm-1, associated with the C-H stretching vibration of the-CH2-group adjacent to COO-. This new group is introduced by the substitution reaction of ClCH2COOH with the -OH in AHPG. According to previous studies, the analysis of the infrared spectrum indicates that CPG has been successfully prepared (Fig. 2C) [16]. PG is rich in hydroxyl and carboxyl groups, both of which serve as electron-donating groups. As a result, PG has a negative potential for aqueous solution. To prove the successful modification of carboxymethylation, the potential values of AHPG and CPG in aqueous solutions were measured. 0.5 wt% at a concentration of 0.5 wt%; AHPG has a potential of –36.5 ± 2.8 mV, whereas CPG has an potential of –44.9 ± 1.3 mV (Fig. S2). When compared to the hydroxyl group, the carboxyl group has a greater electronegativity than the hydroxyl one; when compared to the hydroxyl group, the carboxyl group is more likely to ionize and release H+to become negatively charged. At the same concentration, the potential of CPG is more negative than that of AHPG, which is explained by the fact that CPG contains more carboxyl groups, making the potential of CPG lower. This indicates successful modification with carboxymethyl groups. In AHPG and CPG, the -COOH groups will consume NaOH. By back-titrating the NaOH standard solution with an HCl standard solution, the amount of NaOH consumed by AHPG and CPG, respectively, can be obtained. When the HCl standard solution completely neutralizes the excess NaOH, the solution is neutral, and the conductivity has a minimum value. Plot the curve of solution conductivity value as a function of HCl solution volume, AHPG and CPG consumed 15.7 mL and 14.4 mL of HCl standard solution, respectively, at the lowest conductivity point (Fig. 2D, E). By substituting into the formula, the DS values for AHPG and CPG have been calculated as 1.55 and 2.18, respectively. This indicates that CPG contains a greater number of carboxyl groups compared to AHPG, demonstrating that some of the hydroxyl groups in AHPG have undergone substitution reactions, successfully achieving carboxymethylation. Carboxymethylated polysaccharides are typically polyelectrolytes that exhibit broad application potential in various industries such as pharmaceuticals, nutritional supplements, and food processing. Carboxymethylated polysaccharides refer to the introduction of CH2COOH into polysaccharide molecules to react with macromolecular chains [17]. The reaction proceeds in two stages: first, the OH groups of polysaccharides react with alkali to form alkoxy groups, followed by an SN2 reaction between ClCH2COOH and alkoxylated polysaccharides to produce CH2COONa [18]. Studies have shown that carboxymethylation can effectively increase the solubility and viscosity of polysaccharides. The mechanical properties of the colloid were characterized through uniaxial compression testing. PG and CPG stress-strain curves. The colloid remained intact and did not fracture during the compression process (Fig. 3A). According to Fig. 3B, PG, CPG + NGF compressive moduli are 28.23 5.35 kPa and 30.25 5.70 kPa, respectively. The compression strength of PG is 43.58 ± 5.15 kPa, while that of CPG is relatively higher at 45.98 ± 5.04 kPa (Fig. 3C). The addition of NGF seems to lower the compressive strength of CPG, but does not change its later-stage use.Fig. 3The characterization of colloids. A Stress-strain curves of colloids at a constant frequency of 1 Hz. (n = 3). B Compression modulus of PG, CPG and CPG + NGF. (n = 3). *: P < 0.05. C Compression strength of PG, CPG and CPG + NGF. (n = 3). *: P < 0.05. D–F SEM analysis of freeze-dried CPG + NGF structures. Scale bar = 50 μm. (n = 3). G Pore size of freeze-dried PG, CPG and CPG + NGF structures. (n = 3). ns: på 0.05. H Image showing the injection of CPG + NGF from a 26-gauge needle, with no blockage. (n = 3). I Macroscopic images demonstrating the injectability and self-healing properties of the CPG + NGF. (n = 3) The characterization of colloids. A Stress-strain curves of colloids at a constant frequency of 1 Hz. (n = 3). B Compression modulus of PG, CPG and CPG + NGF. (n = 3). *: P < 0.05. C Compression strength of PG, CPG and CPG + NGF. (n = 3). *: P < 0.05. D–F SEM analysis of freeze-dried CPG + NGF structures. Scale bar = 50 μm. (n = 3). G Pore size of freeze-dried PG, CPG and CPG + NGF structures. (n = 3). ns: på 0.05. H Image showing the injection of CPG + NGF from a 26-gauge needle, with no blockage. (n = 3). I Macroscopic images demonstrating the injectability and self-healing properties of the CPG + NGF. (n = 3) Freeze-dried CPG + NGF has a microporous structure with an average pore size of 69.61 ± 9.60 micrometers (Fig. 3D, E). And the average pore size of freeze-dried PG and CPG is 74.01 ± 9.65 and 70.21 ± 5.11 micrometers, respectively (Fig. 3F, G). Traditional hydrogels demonstrate inadequate mechanical properties when it comes to stretching, pressure, and deformation, primarily because of the unevenness in their internal network structure and the irreversibility of their covalent crosslinking points, which significantly restricts their range of applications [19]. Introduce more carboxyl functional groups into the CPG. The role of the carboxyl functional group in self-healing hydrogels is mainly reflected in its participation in the formation of dynamic covalent bonds. Introducing dynamic covalent bonds into hydrogels can significantly enhance the performance of the hydrogels, such as self-healing ability and mechanical properties [20, 21]. This study employs an in situ injection method for material implantation. The direct injection of hydrogel into the lesion area is referred to as in situ injection. This approach not only encapsulates bioactive components and cells within the hydrogel but also effectively fills irregular cavities of the injury while enhancing adhesion to surrounding tissues. Macroscopic and rheological recovery tests are conducted to investigate the self-healing properties and injectability of colloids. When using a needle, they can be continuously injected without clogging (Fig. 3H). Two independent colloids integrate into a new single and complete colloid. By placing the colloid vertically, the integrated colloid can also slide down intact (Fig. 3I). The colloids with the ability to be transplanted and injected are given the capacity to withstand these injectable and self-healing qualities. The elemental composition of the sample was analyzed through EDX spectroscopy. The study indicates that the sample consists of C, N, O, and Cl elements (Fig. S3). Degradability and drug release characteristics of colloids The performance of hydrogels in terms of degradation is essential for their applications. Hydrolysis, enzymolysis, and dissolution are the main ways that hydrogels degrade. Hydrolysis refers to the breaking of polymer chains within the hydrogel in water, which is common in synthetic hydrogels such as PEG and PLA; enzymolysis involves the decomposition of hydrogels through the action of enzymes, suitable for natural polymers such as collagen and hyaluronic acid; dissolution leads to the decomposition of hydrogels through ion exchange or solvent action, such as ionically crosslinked sodium alginate hydrogels. Depending on different uses, there are various requirements for the degradation time of hydrogels. For example, hydrogels used for wound healing should ideally fully degrade within 7 days, whereas hydrogels used for drug release may require 21 days or more. In the treatment of SCI, due to the severe inflammatory attack on the injured area during the initial phase of injury, implants are typically required to degrade slowly over a period of 28 days. In the in vitro degradation experiments, CPG + NGF gradually hydrolyzed in PBS, experiencing a mass loss of over 80.4 ± 3.43% within 32 days (Fig. 4A). This finding highlights the moderate degradation rate of the colloid, making it highly suitable for long-term tissue repair applications. Simultaneously, within the initial four days, lysozyme was released more rapidly, with a release amount of 45.56 ± 1.25%, which may be due to the diffusion of lysozyme through the colloid matrix (Fig. 4B). About 73.60 2.71% of the lysozyme was released from the hydrogel within about 24 days, showing that the colloid containing nerve growth factor (NGF) has the capacity for stable in vivo release of NGF, thereby satisfying the needs of nerve cells for NGF after SCI.Fig. 4The degradability and release properties of colloids. A Degradation curve of CPG + NGF. (n = 3). B NGF release curve of CPG + NGF. (n = 3). C In vivo degradation of CPG + NGF with actual photos. Scale bar = 0.5 cm The degradability and release properties of colloids. A Degradation curve of CPG + NGF. (n = 3). B NGF release curve of CPG + NGF. (n = 3). C In vivo degradation of CPG + NGF with actual photos. Scale bar = 0.5 cm To gain a deeper understanding of the in vivo degradation process of CPG + NGF, the colloid was implanted into the subcutaneous tissue of rats. Observational results showed that these colloids gradually degraded over a period of four weeks, and their degradation rate in vivo was slightly faster than that observed in vitro. This may be due to the accelerated degradation of the colloid by enzymatic hydrolysis in the in vivo environment (Fig. 4C). In vitro biocompatibility testing of colloids By using a live-dead cell staining kit, it is possible to study the survival status of both living and non-living cells simultaneously. When the mixture of Calcein-AM and PI is applied to the co-cultured PC-12 cells, fluorescence microscopy shows a clear difference between live cells (green fluorescence) and dead cells (red fluorescence). PC-12 cells were co-cultured with the colloid over a five-day period;the cells had no discernible cell death; thus, the colloid had good cytocompatibility (Fig. 5A).Fig. 5Cytotoxicity study of colloids and PC12 cell axon growth study. A PC12 cells were co-cultured with the colloids and subjected to live-dead staining on days 1, 3, and 5. Scale bar = 100μm. B, C Cell viability assay of PC12 cells co-cultured with the colloids for 24 and 48 h. D The effect of colloids formulation on PC12 cell axon growth. Scale bar = 50 μm. E Quantitative analysis of axon length. Data are presented as mean ± standard deviation (n = 3). *P < 0.05, ***P < 0.001. F Immunofluorescence analysis of cell development after 7 days using Tuj1 (green). Nuclei were stained with DAPI (blue). Scale bar = 50 μm. G Quantitative analysis of Tuj1-positive cell protein levels. Data are presented as mean ± standard deviation. *P < 0.05, ****P < 0.0001 Cytotoxicity study of colloids and PC12 cell axon growth study. A PC12 cells were co-cultured with the colloids and subjected to live-dead staining on days 1, 3, and 5. Scale bar = 100μm. B, C Cell viability assay of PC12 cells co-cultured with the colloids for 24 and 48 h. D The effect of colloids formulation on PC12 cell axon growth. Scale bar = 50 μm. E Quantitative analysis of axon length. Data are presented as mean ± standard deviation (n = 3). *P < 0.05, ***P < 0.001. F Immunofluorescence analysis of cell development after 7 days using Tuj1 (green). Nuclei were stained with DAPI (blue). Scale bar = 50 μm. G Quantitative analysis of Tuj1-positive cell protein levels. Data are presented as mean ± standard deviation. *P < 0.05, ****P < 0.0001 The results of the CCK8 assay showed that after 24 h of co-culture, cell viability ranged from 97.45 ± 1.61% to 96.07 ± 2.43%. After 48 h, the viability remained at a high level, fluctuating between 93.82 ± 1.70% and 92.30 ± 3.37% (Fig. 5B, C). In summary, the experimental findings highlighted the outstanding biocompatibility of the colloids. Colloids promote cell proliferation and development Axons transmit nerve impulses from the neuron's cell body to neighboring neurons and effector cells, thereby facilitating the transmission of motor and sensory functions. The PC12 cell line originates from chromaffin cells of a pheochromocytoma in the adrenal medulla of mature rats, and they exhibit significant neurite growth in response to NGF. Consequently, the PC12 cell line is widely used in the study of the complexity of the nervous system. In this study, colloids were co-cultured with PC-12 cells, and the axon lengths of these cells were subsequently analyzed. The study found that in the PG group, a minority of PC-12 cells showed a trend of axon growth. In contrast, in the CPG and CPG + NGF groups, the majority of PC-12 cells exhibited strong synaptic growth (Fig. 5D). Quantitative assessment of synaptic length in each group highlighted the advantage of the CPG + NGF group, whose average synaptic length exceeded that of the control group, PG group, and CPG group (Fig. 5E). According to these data, CPG contributes to neurite development. When CPG works in synergy with NGF, a strong synergistic effect is observed. However, the exact mechanisms that contribute to this synergistic effect need to be explored further in detail. One of the main functions of Tuj1 is the process of neuron-specific differentiation. Microtubules are an important component of the cytoskeleton, maintaining cellular structure, promoting mitosis and meiosis, and regulating various functions such as intracellular transport. Tuj1 is present in the cytoplasm, dendrites, axons, and axon terminals of immature neurons [22]. On the seventh day, the Tuj1 protein level in the CPG + NGF group increased to 1.07, surpassing the Sham, PG and CPG groups (1.03, 1.03 and 1.04) (Fig. 5F, G). This finding suggests that CPG can synergize with NGF to promote the development of neural networks. PG polysaccharide itself possesses antioxidant and neurotrophic effects. Carboxymethylation modification can endow polysaccharides with various biological functions, such as antioxidant, hypoglycemic, immunomodulatory, and antitumor effects. Therefore, CPG exhibits stronger biological functions compared to ordinary naturally derived hydrogels. Additionally, the loading of NGF further suggests its ability to promote axonal growth and development. Motor function and signal recovery after SCI In the complex process of SCI repair, the recovery of motor function has become the most important assessment criterion. To measure the extent of motor function recovery in SCI rats after treatment, we conducted gait analysis and BBB scoring. Irregular gait typically stems from reduced muscle tone, cerebellar dysfunction, peripheral nerve damage, or underlying musculoskeletal abnormalities. Twelve weeks post-surgery, we conducted gait analysis. The sham operation group showed stable and strong gait, which was consistent with the characteristics of the sham surgery group. In contrast, the injured group showed shortened stride length and increased step count, indicating significant impairment in toe movement ability. All treatment groups demonstrated varying degrees of gait recovery, with the CPG + NGF group showing the gait pattern closest to the sham surgery group, indicating the best motor function recovery (Fig. 6A). The PG group had the following gait lengths:2.34 ± 0.32 cm for the PG group, 2.42 ± 0.21 cm for the CPG group, and 2.78 ± 0.19 cm for the CPG + NGF group, respectively. Notably, the stride length of the CPG + NGF group approached that of the sham surgery group at 5.14 ± 0.08 cm (Fig. 6B). Furthermore, in terms of swing distance, the CPG + NGF group achieved 3.24 ± 0.13 cm, which is also close to the sham surgery group’s 1.88 ± 0.14 cm (Fig. 6C). The different levels of white matter and gray matter pathways and neuronal regeneration among the various treatment groups may have led to the differences in gait recovery. Additionally, inconsistent muscle tension caused by atrophied lower limb muscles also affected the recovery of gait.Fig. 6Functional Recovery Following SCI. A Representative footprint patterns of different groups at 12 weeks post-SCI. Scale bar = 2.5 cm. B Semi-quantitative analysis of stride length in footprint tests. Data are presented as mean ± SD (n = 5). **P < 0.01. C Semi-quantitative analysis of swing distance in footprint tests. Data are presented as mean ± SD (n = 5). **P < 0.01,***P < 0.001. D BBB scores of rats at 12 weeks post-SCI. Data are presented as mean ± SD (n = 5). **P < 0.01. E Histological analysis of spinal cord tissue, using H&E staining. Scale bar = 1 mm Functional Recovery Following SCI. A Representative footprint patterns of different groups at 12 weeks post-SCI. Scale bar = 2.5 cm. B Semi-quantitative analysis of stride length in footprint tests. Data are presented as mean ± SD (n = 5). **P < 0.01. C Semi-quantitative analysis of swing distance in footprint tests. Data are presented as mean ± SD (n = 5). **P < 0.01,***P < 0.001. D BBB scores of rats at 12 weeks post-SCI. Data are presented as mean ± SD (n = 5). **P < 0.01. E Histological analysis of spinal cord tissue, using H&E staining. Scale bar = 1 mm Postoperatively, except for the sham surgery group, all groups of rats immediately exhibited hindlimb paralysis, with BBB scores close to zero. Over the next 12 weeks, the BBB scores of the injured group did not exceed 4, with no significant compensatory recovery. An increase in BBB scores throughout time was noted in the treatment groups. Starting from the fourth week post-surgery, the rats in the PG, CPG, and CPG + NGF groups showed significantly higher BBB scores compared to the injured group (Fig. 6D). At 12 weeks post-surgery, the BBB score for the CPG + NGF group was 14.06 ± 0.35, surpassing all other treatment groups. The fact that CPG + NGF can greatly improve the motor function recovery after SCI is highlighted by this. CPG + NGF has been used in cell experiments to show that it may encourage axonal growth and development. This possibility seems to be supported by the recovery of motor function in rats. Subsequent verification of relevant in vivo indicators will be conducted. Repair of spinal cord tissue In situ injection can effectively fill irregular lacunae of injuries while achieving better adhesion to surrounding tissues. After 12 weeks of surgery, the rats were put to sleep, and the spinal cord was entirely removed. H&E staining was then performed. Only the injured group exhibited a lack of significant tissue growth. The CPG + NGF group had more new tissue compared to other treatment groups (Fig. 6E). In comparison to the sham-operated group, the spinal cord injury group exhibited a significantly higher incidence of demyelination. In contrast, the protection of myelin tissue by CPG + NGF was better than that of the injury group (Fig. S4). Therefore, the results indicate that the CPG + NGF prepared in this study significantly promoted the growth and infiltration of nerve cells and the recovery of tissue. Microenvironment and neurogenesis in the damaged area Colloids demonstrate the ability to fill the cavities caused by incisional injuries. A glial scar is formed in the injured spinal cord by various cells working together, including activated astrocytes, oligodendrocyte precursor cells, microglia, fibroblasts, and pericytes. The glial scar can restrict the dissemination of neuroinflammation to nearby spinal cord tissues; at the same time, reactive astrocytes and other cells within the neuroglial scar will increase the expression of CSPGs [17, 23]. During the subacute and chronic phases of SCI, the mature glial scar and upregulated CSPGs become factors inhibiting axonal regeneration and cellular differentiation [18]. The neuroglial scar serves as a physical and chemical barrier that impedes the repair of spinal cord injuries (SCI), primarily due to its elevated levels of inhibitory proteins, such as CSPGs and myelin proteins, which restrict axonal regeneration and the restoration of motor and sensory functions [18, 24]. As a result, a potential approach to promote repair and healing in spinal cord injuries is to diminish the inhibitory effects of CSPGs. By using CS56 antibody for immunohistochemical staining, the expression of CSPGs was significantly detected at the injury site (Fig. 7A). This not only indicates the presence of astrocytes but also shows a large number of infiltrating cells secreting CSPGs gathering around the injury. In comparison to the other groups, CPG + NGF markedly decreased the accumulation of CSPGs in the injured spinal cord (Fig. 7B), suggesting the potential effectiveness of this approach in altering the inhibitory microenvironment.Fig. 7The effect of colloids on the SCI microenvironment and axonal growth in vivo. A After 12 weeks of treatment, the CSPGs in the injured environment were analyzed using immunofluorescence labeling with CS56 (red). Nuclei were stained with DAPI (blue). Scale bar, 50 μm. B Quantitative analysis data of CSPGs fluorescence intensity are presented as mean ± SD (n = 5). **P < 0.01,***P < 0.001. C After 12 weeks of treatment, the glial scar and neurogenesis in the injured environment were analyzed using double immunofluorescence labeling with GFAP (green) and Tuj1 (red). Nuclei were stained with DAPI (blue). Scale bar, 50 μm. D, E Quantitative analysis data of GFAP and Tuj1 fluorescence intensity are presented as mean ± SD (n = 5). *P < 0.05, **P < 0.001, ****P < 0.0001. F Extraction and processing of spinal cord tissue. G, H ELISA Analysis of TGF-β and TNF-α in spinal cord tissue. Presented as mean ± SD (n = 5). *P < 0.05, **P < 0.001 The effect of colloids on the SCI microenvironment and axonal growth in vivo. A After 12 weeks of treatment, the CSPGs in the injured environment were analyzed using immunofluorescence labeling with CS56 (red). Nuclei were stained with DAPI (blue). Scale bar, 50 μm. B Quantitative analysis data of CSPGs fluorescence intensity are presented as mean ± SD (n = 5). **P < 0.01,***P < 0.001. C After 12 weeks of treatment, the glial scar and neurogenesis in the injured environment were analyzed using double immunofluorescence labeling with GFAP (green) and Tuj1 (red). Nuclei were stained with DAPI (blue). Scale bar, 50 μm. D, E Quantitative analysis data of GFAP and Tuj1 fluorescence intensity are presented as mean ± SD (n = 5). *P < 0.05, **P < 0.001, ****P < 0.0001. F Extraction and processing of spinal cord tissue. G, H ELISA Analysis of TGF-β and TNF-α in spinal cord tissue. Presented as mean ± SD (n = 5). *P < 0.05, **P < 0.001 Astrocytes, which are the most plentiful cell population in the spinal cord, play a number of important functions in maintaining ionic homeostasis, regulating neurotransmitter metabolism, maintaining the integrity of the blood-spinal cord barrier, and inflammatory defense. They not only provide energy support for neurons but also help promote the development and plasticity of synapses [25, 26]. SCI can activate the expression of astrocytes, which can then turn into reactive astrocytes [27]. Reactive astrocytes multiply around the injury site to create a glial scar, effectively separating the necrotic tissue from the adjacent healthy tissue. In the early stages of SCI, the glial scar can help restrict microbial infections and the spread of inflammation. However, later recruitment of other pro-inflammatory factors can cause dysfunction of the tissue within and around the scar [28], leading to the massive activation and proliferation of reactive astrocytes, overexpression of GFAP [29], and synthesis of a large amount of CSPGs, which hinders axonal regeneration. Tuj1 was used to stain GFAP twice (Fig. 7C). All treatment groups exhibited higher levels of GFAP expression compared to the sham surgery group. Significantly decreased GFAP expression was seen in the CPG and CPG + NGF groups (Fig. 7D). It is possible to suggest that the development of glial scars can be effectively inhibited by CPG. Apart from the fact that Tuj1 can also label the axons of neuronal cells, it is also a marker for the immature neurons. Tuj1 expression was observed in all treatment groups, with significantly higher expression in the CPG + NGF group compared to the others (Fig. 7E). The results suggest that CPG can promote axonal regeneration to some extent, and when loaded with NGF, its effect can be further enhanced. Transforming growth factor β1 (TGF-β1) promotes the synthesis and secretion of CSPGs by regulating related signaling pathways. These two components exhibit close synergistic or regulatory relationships in physiological and pathological processes such as tissue repair and neural regeneration. In central nervous system injury repair, TGF-β1 induces upregulation of CSPGs expression in injured areas by glial cells. CSPGs, as primary components of glial scar formation, can both limit inflammatory spread and impede axonal regeneration and functional recovery [2–5]. To investigate the potential mechanisms underlying the reduction of CSPGs, this study measured TGF-β1 levels in the rat spinal cord. Results demonstrated that both PG and CPG implants significantly decreased spinal cord TGF-β1 content, with CPG showing a more pronounced effect. Furthermore, CPG effectively reduced TNF-α levels in spinal cord tissue. These findings suggest that the combined use of CPG and NGF may create a favorable microenvironment for repairing axonal damage (Fig. 3F–H). The impact of hydrogel treatment on the main organs of rats To further understand the biocompatibility of hydrogels in vivo, we performed H&E staining on the major organs of rats that had received hydrogel treatment. The results showed that the hydrogel treatment did not cause an inflammatory response in the organs, indicating that the hydrogels have good biocompatibility in vivo and can be used for treatment within the body (Fig. S5). SOD-1 is crucial in the oxidative stress pathway [30–32]. According to the data, at the injury location, CPG can decrease the expression of SOD-1. This may indicate that CPG can protect the damaged area from excessive immune attack. It optimizes the immune microenvironment at the injury site, thereby promoting an environment conducive to axonal sprouting and neural development. Studies have indicated that peach gum and NGF display neurotrophic properties. PG polysaccharide can be changed carboxyethylly to improve the neurotrophic activity of the polysaccharides. The carboxymethylated polysaccharides demonstrate strong antioxidant capacity, which is associated with their electronegativity and higher-order structure. (•OH) High scavenging ability was shown by xymethylated Siraitia grosvenorii polysaccharides against hydroxyl and DPPH radicals(•OH). While preserving the triple-helix structure of Siraitia grosvenorii polysaccharides, introducing an appropriate amount of CH2COOH into the polysaccharide molecules can improve their antioxidant activity. This may be attributed to the introduction of CH2COOH, which activates previously inactive compounds. The primary role of the human immune system is to protect against pathogen invasions while also ensuring the maintenance of normal physiological functions. Introducing CH2COOH into polysaccharide molecules not only increases polysaccharide solubility but also enhances the interaction between polysaccharides and macrophages, effectively improving the immunomodulatory activity of polysaccharides. Carboxymethylated polysaccharides not only significantly improve cytokine levels in rats but also markedly enhance the phagocytic function of their monocyte-macrophage system. These may be potential mechanisms by which CPG + NGF improves the microenvironment of the injured site and promotes the repair of damaged axons. Subsequent studies will investigate the specific mechanisms involved. The impact of hydrogel treatment on the main organs of rats To further understand the biocompatibility of colloids in vivo, we performed H&E staining on important organs of rats treated with colloids (Fig. 8). The results showed that colloid treatment did not cause inflammatory responses in the organs, indicating that colloids have good biocompatibility in vivo and can be used for treatment within the body.Fig. 8Colloids toxic effects on tissues and organs in vivo. At the twelfth week post-operation, perform H&E staining on the vital organs of rats treated with colloids to observe for any significant inflammatory response. Scale bar = 100 μm Colloids toxic effects on tissues and organs in vivo. At the twelfth week post-operation, perform H&E staining on the vital organs of rats treated with colloids to observe for any significant inflammatory response. Scale bar = 100 μm Discussion Carboxymethylation modification optimizes the physicochemical properties of peach gum hydrogel SCI is difficult to repair due to irreversible nerve damage and an inhibitory microenvironment [1]. PG has good biocompatibility but limited application owing to poor solubility and mechanical properties [7, 9]. In this study, alkaline hydrolysis and carboxymethylation were used to prepare CPG, verified by infrared spectroscopy and the substitution degree. The new characteristic peak at 1326 cm⁻¹ and increased substitution degree (2.18) confirmed successful modification. Carboxymethylation improved solubility, electronegativity and mechanical strength; the porous structure (~70 μm), injectability and self-healing ability enable CPG to fill irregular injury cavities and fit surrounding tissues, overcoming the defects of conventional natural hydrogels [15, 16, 19]. CPG + NGF shows excellent biocompatibility and sustained release In vitro experiments confirmed that CPG + NGF had outstanding cytocompatibility, with PC-12 cell viability above 92% within 48 h. Meanwhile, CPG + NGF significantly promoted neurite outgrowth and Tuj1 expression, better than PG and CPG alone. This is attributed to the enhanced neurotrophic and antioxidant activity of PG after modification, as well as the sustained release of NGF [10, 17]. The in vitro release test showed that about 73.6% of NGF was released within 24 days, matching the long-term demand of SCI repair, avoiding the rapid failure of direct NGF application and realizing stable neurotrophic support [11]. CPG + NGF effectively promotes SCI repair in vivo In vivo results showed that CPG + NGF significantly improved the motor function of SCI rats, with a BBB score up to 14.06 ± 0.35 at 12 weeks, and gait parameters close to the sham group. Histological and immunofluorescence proved that CPG + NGF filled the injury cavity, reduced demyelination and promoted tissue regeneration. It also down-regulated the expression of CSPGs and GFAP, inhibited glial scar formation, and reduced TGF-β1 and TNF-α levels to improve the inflammatory microenvironment [17, 18, 23, 24]. The reduction of SOD-1 indicated alleviated oxidative stress, protecting neurons from secondary injury [30–32]. Advantages and limitations of CPG + NGF Compared with hyaluronic acid and chitosan hydrogels, CPG + NGF has better mechanical properties, simple preparation, low cost and good degradability, suitable for clinical translation. However, the regulatory mechanism of microenvironment remains unclear, drug release kinetics needs optimization, and long-term safety requires verification. Future research will explore signaling pathways, optimize release profiles, and conduct comparative studies with other biomaterials. Conclusion In summary, this study utilized native peach gum as the base material for carboxymethylation treatment and loaded it with NGF. A porous structure, excellent mechanical qualities, rheological characteristics, and self-healing ability of the produced CPG + NGF are all present. Through co-culture with PC12 cells, it was found that CPG + NGF has good biocompatibility and can promote axonal elongation, growth, and development. After implantation in vivo, CPG + NGF can fill the cavity at the injury site, improve the microenvironment of the damaged area, and promote the repair of injured nerves. Ultimately, rats that received treatment with CPG + NGF exhibited notable enhancement in hindlimb motor function. The raw materials used in this study are easy to obtain, and the preparation process is simple, which is conducive to production and preservation. CPG exhibits robust mechanical properties, achieving both structural support and functional factor delivery without complex chemical modifications. In contrast, hyaluronic acid hydrogels demonstrate extremely low mechanical strength, while chitosan requires specialized dual-network modification to enhance its mechanical performance. The acetyl bonds in CPG can be controlledly degraded under specific acidic conditions, aligning with the cyclical demands of neural repair. Hyaluronic acid degrades too rapidly to match the long-term healing process of neural tissues, whereas chitosan, though biodegradable, lacks recyclability. This study has several limitations: 1. Although experimental results indicate that CPG + NGF can improve the immune microenvironment at SCI sites and promote axonal repair, the underlying mechanisms remain unclear. It is well-established that post-injury pathological changes in the spinal cord are highly complex. Taking glial scar tissue as an example, while its excessive proliferation hinders axonal growth and certain released substances exacerbate axonal damage, its proliferation also inhibits the distant dissemination of inflammatory factors, thereby reducing damage to normal tissues. Therefore, investigating the mechanisms of implantable materials in SCI repair is crucial for improving material performance. 2. The drug release kinetics of CPG + NGF require further study. Given the complex and prolonged pathological process of SCI, adjusting drug release concentration and rate according to specific conditions at different injury stages presents a challenge for implantable materials. 3. Future research will compare the functional characteristics of CPG with common natural/synthetic macromolecular hydrogels. Supplementary information Supplementary information Supplementary information